Congenital Aplastic Anemia Overview

Save information for later
Sign Up

Learn About Congenital Aplastic Anemia

View Main Condition: Anemia

What is the definition of Congenital Aplastic Anemia?
Congenital aplastic anemia is a rare, serious condition where an infant is born with an abnormality of the bone marrow that leads to inadequate production of red and white blood cells (erythrocytes and granulocytes) and platelets (cell fragments that produce blood clotting). Infants born with congenital aplastic anemia often have several other congenital abnormalities, such as small heads, kidney abnormalities, abnormalities of the forearms and thumbs, other skeletal abnormalities, heart and lung defects, abnormalities of the urinary and genital tracts, and an increased risk of developing cancers, such as gastrointestinal malignancies and leukemia.
What are the symptoms of Congenital Aplastic Anemia?
Symptoms of congenital aplastic anemia include fatigue, pale skin, shortness of breath, rapid or irregular heart rate, headache, dizziness, fever, frequent or prolonged infections, rash, bruising easily, nosebleeds and bleeding gums, and uncontrolled bleeding. In severe cases, congenital aplastic anemia can be fatal.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Congenital Aplastic Anemia?
While there is no cure for congenital aplastic anemia, treatment includes red blood cell and platelet transfusions; immunosuppressant medications, such as cyclosporine (Gengraf, Neoral, and Sandimmune) and anti-thymocyte globulin; corticosteroids; and bone marrow stimulants, such as the colony-stimulating factors, sargramostim (Leukine), filgrastim (Neupogen), pegfilgrastim (Neulasta), epoetin alfa (Epogen/Procrit), and eltrombopag (Promacta). Antibiotics or antivirals may be administered for infections. Some selected individuals with severe aplastic anemia may be considered for stem cell transplant.
Who are the top Congenital Aplastic Anemia Local Doctors?
Dr. Ambuga R. Badari
Hematology Oncology | Hematology | Oncology
Dr. Ambuga R. Badari
Hematology Oncology | Hematology | Oncology

Ochsner Clinic LLC

1514 Jefferson Hwy, 
New Orleans, LA 
 (4.3 mi)
504-842-3000
Languages Spoken:
English, Georgian, Hindi, Kannada, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Ambuga Badari is a Hematologist Oncology specialist and a Hematologist in New Orleans, Louisiana. Dr. Badari and is rated as an Experienced provider by MediFind in the treatment of Congenital Aplastic Anemia. His top areas of expertise are Thrombocytopenia, Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Badari is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
View All Doctors
What are the latest Congenital Aplastic Anemia Clinical Trials?
The Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia: an Ethnographic Study
The Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia: an Ethnographic Study
Enrollment Status: Recruiting
Publish Date: February 26, 2025

Background: Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children with FA may have abnormal features; these may include a small head and eyes and issues with their internal organs. Young adults have a much higher risk of cancer. To screen for these cancers, people with FA may need to pursue many visits with different doctors. This constant need for cancer scr...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Enrollment Status: Recruiting
Publish Date: February 26, 2025

Background: Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especially squamous cell carcinoma (SCC). These cancers usually appear first in the mouth, esophagus, and genital and anal areas. Early detection of SCCs may help improve survival rates for people with FA.

View All Clinical Trials